The latest of new obesity medications has sparked widespread attention and discussion. These agents, often targeting metabolic pathways, seem to provide substantial weight reduction for patients struggling with excess weight. However, questions remain regarding their future effectiveness, possible adverse reactions, and accessibility for a diverse